MetLife board approves $3 billion share buyback authorization
MetLife Inc. secured board approval for a $3 billion share repurchase authorization, adding to the $400 million remaining from its April 2025 plan. CEO Michel Khalaf highlighted the company's financial strength and commitment to shareholder value under the New Frontier strategy as key drivers for the move.
*this image is generated using AI for illustrative purposes only.
MetLife Inc. (NYSE: MET) announced that its board of directors has approved a new $3 billion authorization for the repurchase of its common stock. This decision reflects management’s confidence in the insurer’s long-term financial outlook and its continued ability to generate capital. The new authorization is incremental to the approximately $400 million remaining under the company’s prior share repurchase program, which was announced in April 2025.
The total available capital return capacity now stands at approximately $3.4 billion, combining the fresh authorization with the residual balance from the previous plan. This significant allocation underscores MetLife’s commitment to deploying capital where it creates the greatest long-term value for shareholders, consistent with its New Frontier strategy.
"This new share repurchase authorization reflects our confidence in MetLife’s long-term outlook and continued ability to generate capital," said Michel Khalaf, President and Chief Executive Officer of MetLife. "Our diversified business portfolio, financial strength and disciplined execution continue to support durable growth and attractive returns."
Capital Allocation Strategy
MetLife emphasized that its diversified business portfolio and financial strength support this decision. The company stated that disciplined execution continues to support durable growth and attractive returns. Under the New Frontier strategy, MetLife remains committed to optimizing capital deployment to enhance shareholder value.
| Metric | Value |
|---|---|
| New Repurchase Authorization | $3 billion |
| Remaining Prior Authorization | ~$400 million |
| Total Available Capacity | ~$3.4 billion |
| Prior Authorization Date | April 2025 |
About MetLife
MetLife, Inc., through its subsidiaries and affiliates, is one of the world’s leading financial services companies. Founded in 1868, it provides insurance, annuities, employee benefits, and asset management to individual and institutional customers. The company operates in more than 40 markets globally, holding leading positions in the United States, Asia, Latin America, Europe, and the Middle East.
How might MetLife's increased capital return via share buybacks impact its dividend growth trajectory in the coming fiscal years?
What specific operational metrics or profitability targets under the 'New Frontier' strategy must MetLife achieve to sustain this level of capital deployment?
How will this $3.4 billion repurchase capacity influence MetLife's competitive positioning against peers like Prudential or Aflac in attracting institutional investors?
16
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
